Detalhe da pesquisa
1.
Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808.
Cancer
; 120(7): 1010-7, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24382782
2.
Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002.
Br J Haematol
; 165(1): 102-11, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24428673
3.
Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance).
Haematologica
; 99(1): 111-5, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24077846
4.
P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808.
Blood
; 116(9): 1413-21, 2010 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-20522709
5.
Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance).
Blood Adv
; 2(14): 1705-1718, 2018 07 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30030269
6.
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621.
J Clin Oncol
; 22(21): 4290-301, 2004 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15514371
7.
Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101.
J Clin Oncol
; 28(29): 4500-6, 2010 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20697069
8.
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).
Blood
; 101(1): 6-14, 2003 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12393429